Correlation Between MediciNova and Neurosense Therapeutics

Can any of the company-specific risk be diversified away by investing in both MediciNova and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MediciNova and Neurosense Therapeutics, you can compare the effects of market volatilities on MediciNova and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Neurosense Therapeutics.

Diversification Opportunities for MediciNova and Neurosense Therapeutics

-0.4

Correlation Coefficient

MediciNova  Neurosense Therapeutics

Very good diversification

The 3 months correlation between MediciNova and Neurosense is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between MediciNova and Neurosense Therapeutics

Given the investment horizon of 90 days MediciNova is expected to under-perform the Neurosense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, MediciNova is 2.88 times less risky than Neurosense Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Neurosense Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  104.00  in Neurosense Therapeutics on October 6, 2024 and sell it today you would earn a total of  15.00  from holding Neurosense Therapeutics or generate 14.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

MediciNova  vs.  Neurosense Therapeutics

MediciNova

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Neurosense Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Neurosense Therapeutics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with MediciNova and Neurosense Therapeutics

The main advantage of trading using opposite MediciNova and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.

The idea behind MediciNova and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.